Seven Bridges

Seven Bridges

Accelerate discovery with a complete bioinformatics ecosystem.

Founded 2009

Boston, United States 146 employees Acquired Total: $118.99M Biotechnology, Pharmaceutical

Seven Bridges is a pioneering entity in the bioinformatics landscape, strategically positioned to transform precision medicine. Established in 2009, the company offers a comprehensive ecosystem designed to expedite discovery through an intricate understanding of biomedical data. Their robust platform, enhanced by cutting-edge analytic tools and a wealth of services expertise, underpins breakthrough discovery and drug development initiatives. Clients span the leading edges of academia, biotechnology, government sectors, hospitals, and pharmaceuticals.

The company has forged significant collaborations with some of the globe's most extensive genomics projects, effectively becoming a lynchpin in the efficient large-scale analysis of biomedical information.

Headquartered in the United States, Seven Bridges received acquisition investment from Velsera on 01 January 2023, underscoring its potential and allure to investors in the burgeoning fields of Biotechnology and Pharmaceutical applications.

Funding Stage	Amount	Investors	Lead Investors	Date
Acquisition	Undisclosed	1	Velsera	01 Jan 2023
Series C	$15.00M	-		01 Apr 2021
Series B	$50.00M	-		01 Apr 2018
Series A	$45.00M	1	Kryssen Capital	01 Feb 2016
Grant	$2.99M	1	Genomics England	01 Mar 2015
Seed	$3.00M	-		01 Sep 2014
Seed	$3.00M	-		01 Jan 2014

Funding Stage

Amount

Investors

Lead Investors

Date

Acquisition

Undisclosed

Velsera

01 Jan 2023

Series C

$15.00M

01 Apr 2021

Series B

$50.00M

01 Apr 2018

Series A

$45.00M

Kryssen Capital

01 Feb 2016

Grant

$2.99M

Genomics England

01 Mar 2015

Seed

$3.00M

01 Sep 2014

Seed

$3.00M

01 Jan 2014

FAQ About Seven Bridges

Accelerate discovery with a complete bioinformatics ecosystem.

Seven Bridges was founded in 2009.

Seven Bridges is headquartered in Boston, United States.

Seven Bridges operates in Biotechnology and Pharmaceutical. Its work centres on bioinformatics, precision medicine, biomedical data analysis and genomics projects. Its customers include Biopharma Companies, Healthcare Researchers and Government Entities.

Seven Bridges has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.

Seven Bridges has approximately 146 employees.

Seven Bridges has completed 7 funding rounds, raising a total of $118.99M. The latest funding stage is Acquired.

Seven Bridges offers: End-to-end Bioinformatic Solutions, Collaborative Research and Development, Data and Compute Infrastructure, Security and Compliance Features, Analytic Workflows and Algorithms, Centralized Data Storage.

Top alternatives and competitors to Seven Bridges include Enable Medicine, Lifebit, 赛纳生物科技(北京)有限公司, Thermo Fisher Scientific, Diffuse Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Seven Bridges and Enable Medicine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Seven Bridges

Services & Products

Target Customers

Funding Rounds & Investors (7)

Seven Bridges Alternatives & Competitors

FAQ About Seven Bridges